Olga Bruskina

1.3k total citations
15 papers, 912 citations indexed

About

Olga Bruskina is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olga Bruskina has authored 15 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olga Bruskina's work include Coronary Interventions and Diagnostics (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Acute Myocardial Infarction Research (6 papers). Olga Bruskina is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Acute Myocardial Infarction Research (6 papers). Olga Bruskina collaborates with scholars based in Germany, Netherlands and United States. Olga Bruskina's co-authors include Albert Schömig, Julinda Mehilli, Raisuke Iijima, Robert A. Byrne, Adnan Kastrati, S. Schulz, Gjin Ndrepepa, Steffen Maßberg, A. Kastrati and Jürgen Pache and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Olga Bruskina

15 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Bruskina Germany 11 748 695 274 221 42 15 912
Patrick Serruys Netherlands 11 798 1.1× 575 0.8× 559 2.0× 254 1.1× 20 0.5× 14 966
Masahiro Hada Japan 16 576 0.8× 589 0.8× 475 1.7× 145 0.7× 26 0.6× 136 853
Nicholas Amoroso United States 11 874 1.2× 870 1.3× 244 0.9× 253 1.1× 38 0.9× 26 1.1k
Marco Bressers Netherlands 13 797 1.1× 597 0.9× 391 1.4× 274 1.2× 8 0.2× 16 887
J Wiedermann United States 9 731 1.0× 351 0.5× 458 1.7× 216 1.0× 13 0.3× 12 875
Matthew R. Selmon United States 13 793 1.1× 381 0.5× 354 1.3× 271 1.2× 8 0.2× 26 882
A. Kastrati Germany 4 326 0.4× 358 0.5× 70 0.3× 84 0.4× 42 1.0× 6 437
Javier Zueco Spain 19 804 1.1× 718 1.0× 379 1.4× 336 1.5× 7 0.2× 70 1.1k
Hans‐Peter Stoll Germany 17 1.0k 1.4× 665 1.0× 285 1.0× 480 2.2× 6 0.1× 42 1.2k
Massimo Ferraro Italy 14 1.2k 1.6× 967 1.4× 567 2.1× 365 1.7× 6 0.1× 35 1.3k

Countries citing papers authored by Olga Bruskina

Since Specialization
Citations

This map shows the geographic impact of Olga Bruskina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Bruskina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Bruskina more than expected).

Fields of papers citing papers by Olga Bruskina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Bruskina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Bruskina. The network helps show where Olga Bruskina may publish in the future.

Co-authorship network of co-authors of Olga Bruskina

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Bruskina. A scholar is included among the top collaborators of Olga Bruskina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Bruskina. Olga Bruskina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Steppich, Birgit, Olga Bruskina, Martin Hadamitzky, et al.. (2018). Ultrasound-guided thrombin injection for treatment of femoral artery pseudoaneurysm with concomitant AV-fistula – a retrospective single centre experience. VASA. 47(6). 507–512. 1 indexed citations
2.
Schulz, S., Tibor Schuster, Julinda Mehilli, et al.. (2009). Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. European Heart Journal. 30(22). 2714–2721. 164 indexed citations
3.
Byrne, Robert A., Raisuke Iijima, Julinda Mehilli, et al.. (2009). Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer. JACC: Cardiovascular Interventions. 2(4). 291–299. 129 indexed citations
4.
Mehilli, Julinda, Adnan Kastrati, Robert A. Byrne, et al.. (2009). Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology. 53(19). 1760–1768. 124 indexed citations
5.
Finn, Aloke V., Jae Sang Oh, Michael J. Hendricks, et al.. (2009). Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo. American Heart Journal. 157(2). 383.e1–383.e8. 9 indexed citations
6.
Kufner, Sebastian, Jörg Hausleiter, Gjin Ndrepepa, et al.. (2009). Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis. JACC: Cardiovascular Interventions. 2(11). 1142–1148. 19 indexed citations
7.
8.
Adriaenssens, Tom, Robert A. Byrne, Alban Dibra, et al.. (2008). Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. European Heart Journal. 29(23). 2868–2876. 79 indexed citations
9.
Mehilli, Julinda, Robert A. Byrne, Aleksandra Wieczorek, et al.. (2008). Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. European Heart Journal. 29(16). 1975–1982. 143 indexed citations
10.
Iijima, Raisuke, Gjin Ndrepepa, Julinda Mehilli, et al.. (2007). Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment. Clinical Research in Cardiology. 97(3). 160–168. 9 indexed citations
11.
12.
13.
Iijima, Raisuke, Gjin Ndrepepa, Julinda Mehilli, et al.. (2007). Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. American Heart Journal. 154(4). 688–693. 84 indexed citations
14.
Ndrepepa, Gjin, Julinda Mehilli, Olga Bruskina, et al.. (2007). Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Thrombosis and Haemostasis. 98(10). 852–857. 68 indexed citations
15.
Ndrepepa, Gjin, Adnan Kastrati, Julinda Mehilli, et al.. (2006). Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions. Circulation. 114(19). 2040–2046. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Serruys Breakdown of academic impact, for papers by Masahiro Hada Breakdown of academic impact, for papers by Nicholas Amoroso Breakdown of academic impact, for papers by Marco Bressers Breakdown of academic impact, for papers by J Wiedermann Breakdown of academic impact, for papers by Matthew R. Selmon Breakdown of academic impact, for papers by A. Kastrati Breakdown of academic impact, for papers by Javier Zueco Breakdown of academic impact, for papers by Hans‐Peter Stoll Breakdown of academic impact, for papers by Massimo Ferraro
Rankless by CCL
2026